Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial
Published inJACC. Cardiovascular interventions, vol. 13, no. 19, p. 2314-2316
Publication date2020-10-12
Keywords
- Absorbable Implants
- Coronary Artery Disease / therapy
- Drug-Eluting Stents
- Everolimus
- Humans
- Percutaneous Coronary Intervention
- Prosthesis Design
- Sirolimus
- Treatment Outcome
Affiliation
Citation (ISO format)
IGLESIAS, Juan Fernando et al. Ultrathin-strut versus thin-strut drug-eluting stents for primary PCI: a subgroup analysis of the BIOSTEMI randomized trial. In: JACC. Cardiovascular interventions, 2020, vol. 13, n° 19, p. 2314–2316. doi: 10.1016/j.jcin.2020.07.038
Main files (1)
Article (Published version)
Identifiers
- PID : unige:161613
- DOI : 10.1016/j.jcin.2020.07.038
- PMID : 33032722
ISSN of the journal1876-7605